🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/07/2022 | 58,46 | 59,26 | 58,07 | 58,97 | +1,56% | 2,03% | 192.520 |
| 14/07/2022 | 58,22 | 58,63 | 57,13 | 58,07 | -1,11% | 2,58% | 114.134 |
| 13/07/2022 | 57,86 | 59,39 | 56,66 | 58,71 | -0,98% | 4,71% | 97.783 |
| 12/07/2022 | 57,75 | 59,58 | 55,93 | 59,30 | +2,36% | 6,32% | 156.453 |
| 11/07/2022 | 58,60 | 58,88 | 57,52 | 57,93 | -2,25% | 2,32% | 187.391 |
| 08/07/2022 | 59,36 | 59,86 | 58,45 | 59,26 | -1,20% | 2,38% | 190.436 |
| 07/07/2022 | 60,54 | 61,52 | 59,35 | 59,98 | +0,33% | 3,60% | 174.727 |
| 06/07/2022 | 59,79 | 60,99 | 58,71 | 59,78 | +0,42% | 3,81% | 220.252 |
| 05/07/2022 | 55,61 | 59,57 | 55,53 | 59,53 | +5,35% | 7,27% | 356.187 |
| 01/07/2022 | 55,23 | 56,76 | 54,44 | 56,51 | +1,52% | 4,21% | 216.726 |
| 30/06/2022 | 54,13 | 56,12 | 53,44 | 55,66 | +0,84% | 4,94% | 142.186 |
| 29/06/2022 | 54,06 | 55,22 | 53,36 | 55,20 | +1,46% | 3,44% | 85.440 |
| 28/06/2022 | 55,96 | 56,33 | 54,07 | 54,40 | -3,00% | 4,05% | 130.003 |
| 27/06/2022 | 55,93 | 56,55 | 54,45 | 56,09 | +0,68% | 3,76% | 146.514 |
| 24/06/2022 | 55,25 | 56,67 | 53,87 | 55,71 | +1,70% | 5,06% | 378.308 |
| 23/06/2022 | 50,37 | 54,98 | 49,39 | 54,78 | +9,11% | 11,08% | 276.678 |
| 22/06/2022 | 49,16 | 51,71 | 49,15 | 50,21 | +0,10% | 5,20% | 412.131 |
| 21/06/2022 | 49,60 | 51,52 | 49,12 | 50,16 | +3,57% | 4,83% | 614.751 |
| 17/06/2022 | 48,02 | 49,13 | 47,95 | 48,43 | +2,31% | 2,46% | 1.024.638 |
| 16/06/2022 | 47,86 | 47,86 | 46,67 | 47,34 | -4,05% | 2,49% | 215.764 |
| 15/06/2022 | 47,22 | 49,53 | 47,01 | 49,33 | +5,74% | 5,34% | 203.741 |
| 14/06/2022 | 46,77 | 46,80 | 45,27 | 46,66 | +0,36% | 3,27% | 169.758 |
| 13/06/2022 | 47,87 | 48,43 | 46,14 | 46,49 | -6,02% | 4,77% | 226.504 |
| 10/06/2022 | 49,60 | 50,46 | 48,17 | 49,46 | -2,44% | 4,60% | 246.541 |
| 09/06/2022 | 52,50 | 52,94 | 50,55 | 50,70 | -3,57% | 4,56% | 130.645 |
| 08/06/2022 | 52,95 | 53,91 | 52,11 | 52,58 | -1,95% | 3,38% | 140.263 |
| 07/06/2022 | 50,92 | 53,62 | 50,92 | 53,62 | +3,79% | 5,30% | 151.484 |
| 06/06/2022 | 53,44 | 53,44 | 50,53 | 51,67 | -2,47% | 5,44% | 164.147 |
| 03/06/2022 | 53,13 | 54,20 | 51,55 | 52,98 | -1,48% | 4,99% | 179.055 |
| 02/06/2022 | 53,35 | 53,79 | 52,04 | 53,77 | +0,27% | 3,29% | 126.797 |